Related Experiment Videos
Clinical implications of 5-FU modulation
1Roswell Park Cancer Institute, Buffalo, New York, USA.
Abstract:
In recent years, due to the advent of sensitive instrumentation and methodologies, it has been possible to identify parameters that predict the quality of response of individual patients to treatments for specific selected diseases, e.g., colon carcinoma and breast carcinoma. Ongoing studies are attempting to identify sensitive patients in order to select treatment regimens suitable for the individual patient. The critical question that remains is whether the basis for drug resistance is due in part to insufficient delivery of drugs to target tumor cells or to the resistance of target tumor cells by various mechanisms, including, in the case of 5-fluorouracil (5-FU), drug transport, metabolism, expression of the target enzyme thymidylate synthase (dTMPS), depletion of folate cofactors, and/or level of competing substrate deoxyuridine monophosphate. Also in recent years, attempts have been made to delineate mechanisms of resistance to the fluoropyrimidines. On the basis of such studies, it may be possible to develop approaches aimed at the selective modulation of the therapeutic efficacy of these agents in tumor tissues with varying degrees of sensitivity of fluoropyrimidines, e.g., patients with advanced colorectal cancer. One such approach is the use of calcium folinate to modulate the therapeutic efficacy of 5-FU.
Insights
Understanding individual patient response to cancer treatments like 5-fluorouracil (5-FU) is key. Research explores drug delivery and resistance mechanisms, including folate metabolism, to personalize chemotherapy for colorectal cancer.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Predictive biomarkers for cancer treatment response are emerging for diseases like colon and breast carcinoma.
- Individualized treatment selection is a growing focus in oncology.
- Mechanisms of drug resistance, particularly to fluoropyrimidines, are under investigation.
Purpose of the Study:
- To investigate the critical question of whether drug resistance stems from insufficient drug delivery or intrinsic tumor cell resistance mechanisms.
- To delineate the specific mechanisms of resistance to fluoropyrimidines, such as 5-fluorouracil (5-FU).
- To explore strategies for modulating the therapeutic efficacy of fluoropyrimidines in tumors with varying sensitivity.
Main Methods:
- Analysis of parameters predicting patient response to cancer treatments.
- Investigation of 5-fluorouracil (5-FU) resistance mechanisms, including drug transport, metabolism, thymidylate synthase (dTMPS) expression, folate cofactor levels, and deoxyuridine monophosphate.
- Exploration of calcium folinate as a modulator of 5-FU efficacy.
Main Results:
- Identification of predictive parameters for treatment response in specific cancers.
- Delineation of multiple mechanisms contributing to fluoropyrimidine resistance.
- Potential for developing targeted approaches to enhance chemotherapy effectiveness.
Conclusions:
- Understanding drug resistance mechanisms is crucial for optimizing cancer therapy.
- Personalized treatment strategies, potentially involving agents like calcium folinate, can improve outcomes for patients with advanced colorectal cancer.
- Further research into drug delivery and tumor cell resistance pathways will advance individualized cancer treatment.